Medical Devices & Diagnostics — India ↔ EU Trade Facilitation

Bilateral trade · India ↔ EU

What moves on this corridor.

India exports → EU

EUR 450M annually — disposable syringes and needles (India #1 globally, 85% EU market share in some categories), surgical gloves, surgical sutures, wound care products, orthopaedic implants, diagnostic reagents and kits, blood collection tubes, IV cannulas, catheters, examination gloves, hospital furniture

Top India states: Himachal Pradesh (Baddi — largest India pharma and device cluster; syringes, IV fluids), Haryana (Faridabad — surgical instruments), Maharashtra (Mumbai/Pune — diagnostics, orthopaedics), Tamil Nadu (Chennai — hospital equipment, gloves), Rajasthan (Jaipur — Jaipur Foot, orthopaedic prosthetics)

EU exports → India

EUR 950M annually — high-tech diagnostic equipment (CT, MRI, PET — Siemens Healthineers, Philips Healthcare, GE Healthcare EU); surgical robotics (Intuitive Surgical, CMR Surgical); orthopaedic implants (Stryker, DePuy Synthes, Zimmer Biomet EU); cardiovascular devices (Medtronic EU, Boston Scientific); ophthalmic devices (Alcon, Carl Zeiss Meditec)

Top EU buyers: Germany (Fresenius — dialysis, IV solutions; Paul Hartmann — wound care; B.Braun — infusion), France (Sartorius — bioprocessing; bioMérieux — IVD), Netherlands (Philips Healthcare HQ), Sweden (Getinge — sterilisation, surgical; Arjo — patient handling), Italy (Euromed, regional hospital procurement)

Growth rate

+15% CAGR India medical device exports (2019–2024) · Disposables fastest-growing EU export · In-vitro diagnostics +22% CAGR · Digital health devices (wearables, monitoring) +35% CAGR

FTA duty impact

Most EU medical device imports face 0% EU MFN duty already (WHO Pharmaceutical Tariff Elimination Agreement covers many devices). Key changes: surgical instruments (HS 9018): 1.7% → 0% (Day 1 FTA). Hospital furniture (HS 9402): 3.7% → 0% (Year 3). Orthopaedic implants (HS 9021): 0% (MFN already 0%). The real barrier is EU MDR certification — not tariffs.

HS codes & tariff rates

Tariff lines that matter.

HS code	Product	EU MFN	FTA rate
`9018`	Instruments for medical, surgical, dental — syringes, needles, catheters	1.7%	0% (Day 1)
`9021`	Orthopaedic appliances, prostheses — implants, splints	0%	0% (MFN already 0%)
`9022`	X-ray apparatus, CT, MRI — diagnostic imaging	0%	0% (MFN already 0%)
`3006`	Pharmaceutical goods — sterile surgical catgut, sutures, haemostatics	0%	0% (MFN already 0%)
`3822`	Diagnostic reagents — in-vitro diagnostic kits	0%	0% (MFN already 0%)
`4015`	Gloves — rubber examination and surgical	4.7%	0% (Year 3)
`9402`	Medical, surgical furniture — hospital beds, examination tables	3.7%	0% (Year 3)
`9019`	Mechano-therapy, massage, hearing aids — physiotherapy devices	2.5%	0% (Year 3)

HS codes and rates are indicative. Verify on EU TARIC before commercial use.

HS code lookup tool →

EU compliance

Required certifications.

EU MDR 2017/745 (Medical Device Regulation)

Mandatory for all medical devices placed on the EU market. Replaced EU MDD (93/42/EEC). Four risk classes: Class I (low risk — sterile and measuring), Class IIa (medium risk — most active devices), Class IIb (higher risk — implants, blood bags), Class III (highest risk — life-sustaining, cardiac implants). Indian manufacturers must appoint an EU Authorised Representative (AR) and obtain CE marking from a Notified Body (NB) for Class IIa and above. Critical issue: EU MDR NB capacity shortage — certification backlogs of 12–24 months; plan early.

EU MDR 2017/745 · EUDAMED · EU Notified Bodies (BSI, TÜV SÜD, SGS, DEKRA)

EU IVDR 2017/746 (In Vitro Diagnostic Regulation)

Mandatory for all in-vitro diagnostic devices (IVD) in EU — diagnostic reagents, test kits, analysers. More stringent than predecessor IVDD (98/79/EC). Most IVDs reclassified to higher risk class under IVDR — most routine diagnostics now require Notified Body involvement. Indian IVD manufacturers (post-COVID rapid test expansion) must IVDR-certify their EU-bound products by phased deadlines.

EU IVDR 2017/746 · EUDAMED · IVD Notified Bodies

ISO 13485 (Medical Device QMS)

Mandatory quality management system standard for all medical device manufacturers selling to EU. ISO 13485:2016 is required for CE marking (Notified Body will not certify without ISO 13485). Covers: design and development, production, sterile production controls, post-market surveillance, vigilance reporting. All Indian medical device manufacturers for EU must hold ISO 13485 certification.

ISO 13485:2016 · accredited certification bodies

CDSCO (India Medical Device) MDR 2017

India's Medical Devices Rules 2017 (MDR 2017) — the Indian regulatory framework for medical devices. Administered by CDSCO (Central Drugs Standard Control Organisation). Device importers and manufacturers must hold CDSCO registration. CDSCO registration is now harmonised to WHO GHTF device classification (Class A/B/C/D equivalent to EU Class I/IIa/IIb/III). CDSCO registration required before CE-marked EU devices can be sold in India.

CDSCO · MDR 2017 · SUGAM portal

EU Authorised Representative (EC REP)

All non-EU medical device manufacturers (including Indian manufacturers) must appoint an EU Authorised Representative (EC REP) before placing devices on the EU market under EU MDR. The EC REP is legally responsible for the device's EU market compliance, EUDAMED registration, vigilance reporting, and regulatory correspondence with EU competent authorities. EC REP appointment is mandatory — not optional.

EU MDR Art 11 · EUDAMED · EC REP appointment

Sterilisation Compliance (for sterile devices)

Indian manufacturers exporting sterile medical devices (sterile syringes, sterile dressings, sterile implants) to EU must validate their sterilisation processes per ISO 11135 (EO sterilisation), ISO 11137 (radiation sterilisation), or ISO 13683 (steam sterilisation). Sterilisation validation records must be available for Notified Body review. Sterile device packaging must comply with ISO 11607.

ISO 11135 · ISO 11137 · ISO 11607 · EU MDR sterility requirements

EU compliance checker tool →

Bilateral trade flow

India ↔ EU · the directions.

India → EU (Exports)

Disposable syringes and needles (HMD Medical, Hindustan Syringes and Medical Devices, Iscon Surgicals — India dominates global syringe supply); surgical sutures (Endocare, Shalon Medical); examination and surgical gloves (Gunam International); orthopaedic implants (Orchid Orthopedic Solutions, Indu Healthcare); diagnostic reagents (Tulip Diagnostics, Transasia, Agappe Diagnostics); IV cannulas, blood collection tubes (Becton Dickinson India exports); hospital furniture and beds (Stryker-competitive Indian manufacturers)

EU → India (Imports)

High-tech diagnostic imaging (Siemens Healthineers CT/MRI; Philips Healthcare EU; Fujifilm — India procurement); surgical robotics (CMR Surgical — UK, expanding to India); cardiac devices (Medtronic, Boston Scientific — EU manufactured); orthopaedic implants (Stryker, Zimmer — EU factories for India premium market); ophthalmology (Alcon, Carl Zeiss Meditec); haemodialysis (Fresenius Medical Care)

Sector risk framework

Risks · assessment · mitigation.

Risk	Assessment	Mitigation
EU MDR Notified Body backlog — Indian manufacturer cannot obtain CE marking within commercial timeline due to NB capacity shortage	High / High	Begin EU MDR/IVDR Notified Body application process 18–24 months before planned EU market entry. NB capacity is severely constrained (2022–2027 transitional period). Early appointment of NB and early ISO 13485 audit is the only mitigation.
EU Authorised Representative liability — EC REP takes on legal liability for Indian manufacturer's EU MDR compliance	Low / High	EC REP appointment agreement must include: indemnity from Indian manufacturer, ISO 13485 certificate as ongoing condition, incident reporting protocol, and right of EC REP to terminate if Indian manufacturer loses certification.
Post-market surveillance failure — Indian manufacturer does not have EU MDR-compliant post-market surveillance (PMS) system	Medium / High	EU MDR requires continuous post-market surveillance — not just pre-market. Indian manufacturers must implement: EUDAMED registration, vigilance reporting (serious incident within 15 days), PSUR (Periodic Safety Update Report), PMCF (Post-Market Clinical Follow-Up) for implantable and Class III devices.
CDSCO registration delays for EU devices importing to India — Indian market entry for EU medical devices delayed by CDSCO processing backlogs	Medium / Medium	CDSCO SUGAM portal online application has improved processing times but delays remain for Class C/D devices. EU exporters to India should file CDSCO registration 6–12 months before planned India market entry.
Sterile product contamination — batch recall triggered by EU market surveillance authority	Low / Very High	ISO 13485 sterile process validation, incoming raw material testing, and batch retention samples are the primary safeguards. EU MDR vigilance reporting (serious incident within 15 days, field safety corrective action) must be implemented in Indian manufacturer's QMS before EU market entry.

3 Ps · viability analysis

Possibility · probability · plausibility.

Possibility

Is this trade structurally viable?

Yes — India is the world's dominant supplier of low-to-mid technology medical devices (syringes, needles, gloves, sutures, disposables) and is fast developing capability in diagnostics, orthopaedics, and medical electronics. The EU is a major buyer. EU MDR certification is achievable but requires early investment and planning.

Probability

Will this specific mandate close?

Very High for Class I and Class IIa devices (single-use disposables, examination gloves, basic diagnostic kits — EU MDR compliance is simpler). High for Class IIb devices (orthopaedic implants, diagnostic reagents). Moderate for Class III (cardiac, neurological implants — very long CE marking timeline; NB backlog). Low for surgical robotics or AI-based medical devices (EU MDR AI requirements and clinical evidence requirements are demanding).

Plausibility

Does the commercial logic hold?

Fully coherent. India's disposable medical device cost advantage (50–70% below EU manufactured equivalents) is structural — driven by labour, raw material sourcing, and scale. EU hospitals and GPOs (Group Purchasing Organisations) are under budget pressure and actively seek cost-competitive CE-marked alternatives to established EU device brands.

Marketing mix · 10P analysis

The vertical through a 10P lens.

Product

Disposable syringes and hypodermic needles; examination and surgical gloves; surgical sutures and haemostats; IV cannulas and catheters; blood collection tubes; wound care dressings; orthopaedic implants (plates, screws, nails, prostheses); diagnostic reagent kits (IVD); hospital furniture and beds; physiotherapy equipment; non-invasive monitoring devices (pulse oximeters, glucometers).

Price

Indian disposable devices: 40–70% below EU manufactured equivalents. Orthopaedic implants: 30–50% below Stryker/DePuy/Zimmer equivalents. Commission: 4–7% CIF — higher than industrial goods reflecting the compliance complexity investment and longer qualification cycle.

Place

India → EU: air freight (medical grade — sterile products require validated packaging, temperature control for biologics-based kits) from Delhi/Mumbai to Frankfurt/Amsterdam. Sea freight for non-sterile disposables in bulk. Primary EU entry through Netherlands (Rotterdam — efficient medical device import processing) and Germany (Frankfurt — largest EU medical device market).

Promotion

Medica Düsseldorf (November — world's largest medical device trade fair), Arab Health Dubai (January — Middle East + EU buyers present), CMEF India (biennial), MedTech Europe conference, EUHA hearing aids (Frankfurt). AIMED (Association of Indian Medical Device Industry) — India-side trade body.

People

Vinod Kumar Jain — India-side manufacturer qualification, Baddi/Faridabad/Jaipur network, CDSCO compliance intelligence. Amit Jain — EU MDR/IVDR regulatory intelligence, EU Notified Body database, EU hospital procurement and GPO buyer qualification.

Process

Three P filter → ISO 13485 certification verification → EU MDR/IVDR risk class classification → NB appointment status check → EC REP appointment verification → Mandate + NCNDA → EU device distributor / hospital GPO / healthcare group buyer qualification → Samples and technical documentation review → Commercial agreement → Commission.

Physical Evidence

ISO 13485 certificate, CE Declaration of Conformity (EU MDR), Notified Body CE certificate, EC REP appointment letter, EUDAMED UDI (Unique Device Identifier) registration, CDSCO registration (for India imports), sterilisation validation report (if applicable), commission invoice.

Partners

AIMED (Association of Indian Medical Device Industry), CDSCO (Central Drugs Standard Control Organisation) — India. MedTech Europe (EU medical device industry association), SPECTARIS (Germany), SNITEM (France), Notified Bodies: BSI, TÜV SÜD, SGS, DEKRA — EU.

Performance

Target: 3–6 medical device mandates per year. Commission: EUR 15,000–80,000/year (4–7% on EUR 300K–1.5M annual supply). Disposables mandates close faster (6–12 months from introduction); orthopaedic implants and diagnostics mandates take 18–36 months from introduction to commercial supply.

Purpose

India produces the world's syringes, needles, and disposable devices — the essential, unglamorous infrastructure of global healthcare delivery. Making India's medical device manufacturing excellence accessible to EU healthcare systems facing unsustainable procurement cost pressures is commercially and ethically significant.

Practitioner intelligence

What works · what doesn't.

✓ Success conditions

What works

✓ Starting EU MDR Notified Body applications 18–24 months before planned EU market entry — NB backlog means early application is the only way to achieve commercial supply timelines; mandate agreements should include EU MDR milestone dates as KPIs
✓ Targeting EU hospital Group Purchasing Organisations (GPOs — Fresenius, Agfa, Sodexo Healthcare) for disposable device mandates — GPOs purchase in multi-million EUR annual volumes, have established Indian-origin procurement experience, and accept ISO 13485 + CE-marked devices efficiently
✓ Positioning against non-EU Asian alternatives (Malaysian gloves, Chinese syringes) on EU MDR compliance and post-market surveillance traceability — EU hospital procurement increasingly requires verified EU MDR compliance records, not just a CE mark copy
✓ Using Medica Düsseldorf as the primary EU market entry point for Indian medical device manufacturers — Medica attracts 80,000+ EU healthcare buyers in 4 days; an ISO 13485-certified Indian manufacturer with CE-marked products and product samples gets qualified buyer meetings

✗ Failure modes

What doesn't work

✗ Approaching EU medical device buyers without both ISO 13485 and CE marking under EU MDR (not legacy CE under MDD) — EU MDR replaced EU MDD; devices with legacy MDD CE marks have transitional deadlines; EU buyers increasingly require new EU MDR conformity
✗ Neglecting post-market surveillance (PMS) setup before EU market entry — EU MDR requires ongoing PMS from Day 1 of EU sales; not having EUDAMED UDI registration, incident reporting procedures, and PSUR timelines in place before commercial supply is a regulatory violation
✗ Ignoring EC REP appointment until EU distributor agreement is signed — EC REP appointment must happen before any EU market sales, not after; without an appointed EC REP, placing devices on the EU market is illegal under EU MDR Art 11

Commission structure

How we get paid.

Deal type	Rate	Indicative value
Disposable syringes and needles — EU hospital GPO supply	4–5% CIF	EUR 300K–2M annual · ISO 13485 + CE MDR Class I/IIa mandatory
Examination and surgical gloves — EU healthcare distributor	4–5% CIF	EUR 200K–1M annual · ISO 13485 + CE · REACH compliance
Orthopaedic implants — EU distributor or hospital	5–7% CIF	EUR 200K–800K annual · CE MDR Class IIb/III · 18–36 month NB cycle
Diagnostic reagents (IVD) — EU lab or distributor	5–7% CIF	EUR 150K–600K annual · CE IVDR Class A/B/C/D · EUDAMED registration
Hospital furniture and beds — EU hospital procurement	4–5% CIF	EUR 100K–500K annual · CE EN 60601 · CE MDR or EMVS depending on classification
Blood collection tubes and IV cannulas — EU GPO	4–6% CIF	EUR 200K–1M annual · CE MDR Class IIa · High volume, thin margin

Sub-specialisations

Niches we operate in.

Niche

Disposable Syringes & Needles

India manufactures 85%+ of global syringe/needle supply. HMD Medical, Hindustan Syringes, Iscon Surgicals. CE MDR Class I sterile or Class IIa. EU hospital and homecare markets.

4–5% CIF

Niche

Orthopaedic Implants — Jaipur

Orchid Orthopedic Solutions, Hind-Surgicals, Auxein Medical — CE MDR Class IIb/III implants. Jaipur orthopaedic cluster. 30–50% below Stryker/DePuy pricing.

5–7% CIF

Niche

IVD Diagnostic Kits

Post-COVID, Indian IVD manufacturers (Transasia, Tulip, Agappe, J. Mitra) have expanded EU-quality IVD production. CE IVDR Class A/B kits for EU labs and clinics.

5–7% CIF

Niche

Examination Gloves — Rubber

Indian rubber examination gloves (AQL 1.5) for EU medical and non-medical use. CE marking, ASTM D3578/EN 455. Growing post-pandemic procurement.

4–5% CIF

Niche

Hospital Furniture & Beds

Indian hospital furniture manufacturers (Paramount Surgimed, Niti Health) offering ICU beds, examination tables at 40–50% below EU equivalents. CE marking under General Product Safety Regulation.

4–5% CIF

Niche

Medical Electronics — Monitoring Devices

Pulse oximeters, glucometers, digital thermometers, non-invasive BP monitors. Indian manufacturers (BPL Medical, Trivitron, Nasan) with CE MDR Class IIa certification.

5–6% CIF

Active mandates · Medical Devices & Diagnostics

What's open right now.

SELL ISO 13485 certified syringe manufacturer — 2B units/year capacity, CE MDR Class IIa, EU Authorised Representative appointed, 3 EU distributors already, capacity available Baddi, Himachal Pradesh → Germany / Netherlands / France hospital GPOs

SELL Orthopaedic implant manufacturer — CE MDR Class IIb orthopaedic trauma range (plates, screws, nails), ISO 13485, 60% below Stryker pricing, 2 EU distributors sought Jaipur, Rajasthan → Germany / Italy / Spain orthopaedic distributors

BUY German medical device distributor — seeking CE-marked Indian disposable (syringes, IV sets, gloves) range for Germany hospital GPO tender, EUR 800K annual budget Germany → India (Baddi / Faridabad cluster)

SELL IVD diagnostic kit manufacturer — CE IVDR Class B clinical chemistry and haematology reagents, ISO 13485, USFDA registered, seeking EU lab supply contracts Pune, Maharashtra → EU (Germany / France / Netherlands diagnostic labs)

Mandates anonymised. Introduced under NCNDA. Commission on completion. Submit your mandate →

Context & outlook

How this sector is moving.

Historical context

How this sector evolved

◆ India's medical device manufacturing history dates to the 1950s — basic surgical instruments (Jabalpur, MP; Sialkot legacy in Faridabad, Haryana). The industry scaled from the 1980s as India became the global syringe supplier.
◆ The COVID-19 pandemic (2020–22) dramatically accelerated Indian medical device manufacturing — India produced 2B+ vaccine doses (Serum Institute, Bharat Biotech) and scaled disposable device output (syringes, PPE, diagnostic kits) to meet global demand.
◆ EU MDR (2017/745) came into force in May 2021 (delayed from 2020 due to COVID) with transitional periods. The MDR transition created both a compliance challenge and a commercial opportunity for Indian manufacturers — those who completed MDR certification before EU competitors gained market share in the transitional period.
◆ India's PLI scheme for medical devices (INR 3,420 Cr — USD 465M) launched in 2020 — incentivising domestic manufacturing of high-value medical devices (CT scanners, MRI machines, linear accelerators) that India currently imports predominantly from EU and US.

Future outlook 2025–2030

Where this is heading

▶ EU MDR NB backlog resolution — EU Commission and Notified Bodies are adding capacity; backlog expected to reduce from 2026 onwards. Indian manufacturers who have completed application now will benefit from earlier certification.
▶ India high-value medical device manufacturing (PLI scheme) — India manufacturing CT scanners, MRI machines, and cardiac devices domestically. EU reverse import potential for Indian-manufactured high-value imaging equipment targeting emerging markets via EU distributors.
▶ AI-powered medical devices (EU MDR AI provisions) — Indian healthtech companies developing AI diagnostic tools (AI-powered retinal screening, AI ECG interpretation) must demonstrate clinical evidence and EU MDR compliance for AI-based software as a medical device (SaMD).
▶ EU Green Hospital Initiative — EU hospitals reducing single-use device waste; reprocessing of medical devices (validated under EU MDR Annex IX special provisions). Indian reprocessing technology and services for EU hospitals is an emerging mandate category.

India ↔ EU FTA impact

Low-Medium impact

FTA tariff impact is minimal (most devices at 0% already). FTA regulatory cooperation (mutual recognition of QMS audits, CDSCO-EU NCA information sharing) is commercially meaningful but takes years to operationalise. Most significant FTA impact: EU MDR transition provisions may be facilitated through India-EU regulatory cooperation, potentially reducing the 12–24 month NB backlog for Indian manufacturers.

Essential documents

From the document library.

Doc 37

CE / REACH / RoHS Compliance Pack

CE marking overview — EU MDR CE marking specifically addressed

→ Doc 83

Product Compliance & Market Placement Checklist

EU MDR compliance checklist for medical device EU market entry

→ Doc 74

Indian Exporter Export Readiness Checklist

Section D covers medical device-specific documentation (CDSCO, MDR 2017 India)

→

Browse all documents →

Applicable FTAs

FTA

India-EU FTA 2026

Regulatory cooperation — mutual recognition of ISO 13485 audits; CDSCO-EU NCA information sharing; HS 9018 surgical instruments duty Day 1 elimination

FTA

India-UAE CEPA

UAE as medical tourism and device distribution hub for Indian medical devices entering MENA markets

Key markets

Country intelligence for this vertical.

Country

Germany

Medica Düsseldorf; Fresenius, B.Braun, Paul Hartmann — major EU medical device buyers

Country

Netherlands

Philips Healthcare HQ; Dutch hospital procurement; Rotterdam efficient medical device import port

Country

India

Baddi (Himachal Pradesh), Faridabad (Haryana), Jaipur (orthopaedics), Pune (diagnostics)

All 184 country pages →

Standard operating procedure

SOP-34 · Medical Device Export to EU — EU MDR Compliance Protocol

View SOP

Frequently asked

FAQ · Medical Devices & Diagnostics.

What is the difference between EU MDD (old) and EU MDR (new) and why does it matter for Indian exporters?

EU MDD (Medical Devices Directive 93/42/EEC) was the previous EU medical device regulation, under which most Indian manufacturers obtained CE marking. EU MDR (Medical Device Regulation 2017/745) replaced MDD with significantly stricter requirements: mandatory clinical evidence for all devices (not just Class III); post-market surveillance as a continuous obligation; EUDAMED (European Database on Medical Devices) registration of all devices and manufacturers; more stringent Notified Body (NB) scrutiny. Transitional periods: Class III and implantable Class IIb — by December 31, 2027; Class IIa and non-implantable Class IIb — by June 30, 2028 (extended again in 2023). Indian manufacturers with legacy MDD CE marks must initiate EU MDR Notified Body applications now — with NB backlog of 12–24 months, waiting until the transitional deadline is too late.

What is EUDAMED and does an Indian medical device manufacturer need to register on it?

EUDAMED (European Database on Medical Devices) is the EU Commission's central database for medical devices placed on the EU market. Under EU MDR, all medical devices (and their manufacturers) must be registered on EUDAMED before EU market placement. Specifically required: UDI (Unique Device Identifier) registration on EUDAMED for all devices; device registration data (indications for use, clinical data summary, certificates); manufacturer and EU Authorised Representative registration. The EU Authorised Representative (EC REP) appointed by the Indian manufacturer typically manages EUDAMED registration on the manufacturer's behalf. EUDAMED registration is public — EU buyers can verify the compliance status of Indian-origin devices before procurement.

Can an Indian medical device manufacturer sell to the EU without going through an EU distributor?

Yes — but only if the Indian manufacturer has appointed an EU Authorised Representative (EC REP) and has obtained CE marking for all relevant device risk classes. The Indian manufacturer can then sell directly to EU hospitals, GPOs, or retail distributors without an intermediary. However, most Indian medical device manufacturers work with EU distributors (who handle: local regulatory compliance management, hospital tender participation, EU VAT management, product liability coverage, and after-sales support). The EU distributor does NOT replace the EC REP — both are required simultaneously under EU MDR Art 11.

Travelogue Forum

Have a question or insight on Medical Devices & Diagnostics? Start a thread in Markets & Logistics.

Discuss on the Forum →

Explore Further — Across the AJG Network

📚

From the AJG Library

Knowledge base matches

Silicones & Elastomers → Silicone fluids, resins, and elastomers for construction, electronics, medical.

Full Knowledge Library →

🧭

From Scope Scape

Sibling Pages

Peers in the same section

Medical Tourism →

🔍

Authoritative External Sources

Primary + analyst + press

WHO — World Health Organization → Global health statistics, disease surveillance, vaccine guidance 📡 RSS
PubMed → Biomedical and life sciences research literature — MEDLINE database 📡 RSS
The Lancet → Leading peer-reviewed medical journal — clinical research, public health 📡 RSS

🎯

The Guessing Desk

All sources on this topic · filterable

The Guessing Desk — 140 curated sources on "Medical" → Filter the full catalog of 140 authoritative sources and 109 live RSS feeds by this topic. Export to your RSS reader. Th…

Open The Guessing Desk →

Supplier Nation	EU Share	Trend	India Edge / Context
USA	22.5%	→	FDA cleared
Germany	18.5%	↓	Cost
China	12.5%	↑	IVD dominance
India ⭐	2.2%	↑	—
Japan	7.5%	→	Imaging

Dimension	EU	UAE	USA	UK	ASEAN	AUS
Mkt Size	80	68	88	75	60	55
Growth	85	82	85	85	80	78
Entry Ease	48	68	38	48	65	65
Reg Safety	40	62	32	42	58	62
Mkt Open	55	55	48	55	58	60
Commission	85	80	88	85	72	75
FTA Boost	82	82	40	65	60	78

All factsheets at a glance

Search 23,577,134 allfrontierglobal.com data points

33 Medical Devices, Diagnostics and Healthcare Equipment — India ↔ EU

What moves on this corridor.

Tariff lines that matter.

Required certifications.

India ↔ EU · the directions.

Risks · assessment · mitigation.

Possibility · probability · plausibility.

The vertical through a 10P lens.

What works · what doesn't.

What works

What doesn't work

How we get paid.

Niches we operate in.

Disposable Syringes & Needles

Orthopaedic Implants — Jaipur

IVD Diagnostic Kits

Examination Gloves — Rubber

Hospital Furniture & Beds

Medical Electronics — Monitoring Devices

What's open right now.

How this sector is moving.

How this sector evolved

Where this is heading

Low-Medium impact

From the document library.

India-EU FTA 2026

India-UAE CEPA

Country intelligence for this vertical.

Germany

Netherlands

India

FAQ · Medical Devices & Diagnostics.

Strategic Heat Map

Multilateral Corridor Comparison — Global Overlay

Bilateral vs Multilateral Trade Intelligence

Competitive Intelligence — India vs Competing Nations in the EU Market

Seasonal Trade Calendar

ESG Intelligence & EU Taxonomy Alignment

Supply Chain Resilience Intelligence

RoDTEP Benefit Indicator

India-EU FTA Duty Saving Estimator

Every Direction. Every Configuration. Commission-Only.

📊 Vertical monthly · refreshed monthly

Live Medical Devices & Diagnostics intelligence

🎯 Active mandates · 27 total

📘 Standard operating procedures · 13

📍 Cities tagged with Medical Devices & Diagnostics · 8

📄 Long-form essays · 1

📰 Recent blog posts · 1

Cron-refreshed data — every cadence

Explore the AJG knowledge graph

Medical Devices, Diagnostics and Healthcare Equipment — India ↔ EU